Aim Immunotech Stock Price History
AIM Stock | USD 0.23 0.02 9.52% |
Below is the normalized historical share price chart for AIM ImmunoTech extending back to July 12, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of AIM ImmunoTech stands at 0.23, as last reported on the 30th of November, with the highest price reaching 0.24 and the lowest price hitting 0.22 during the day.
If you're considering investing in AIM Stock, it is important to understand the factors that can impact its price. AIM ImmunoTech secures Sharpe Ratio (or Efficiency) of -0.1, which signifies that the company had a -0.1% return per unit of return volatility over the last 3 months. AIM ImmunoTech exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AIM ImmunoTech's Risk Adjusted Performance of (0.07), mean deviation of 3.61, and Coefficient Of Variation of (957.15) to double-check the risk estimate we provide.
At this time, AIM ImmunoTech's Common Stock Shares Outstanding is very stable compared to the past year. As of the 30th of November 2024, Liabilities And Stockholders Equity is likely to grow to about 29.4 M, while Other Stockholder Equity is likely to drop about 251.9 M. . As of the 30th of November 2024, Price To Sales Ratio is likely to drop to 100.52. In addition to that, Price Earnings Ratio is likely to drop to -0.77. AIM Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of July 1996 | 200 Day MA 0.3543 | 50 Day MA 0.25 | Beta (0.36) |
AIM |
Sharpe Ratio = -0.1001
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | AIM |
Estimated Market Risk
5.23 actual daily | 46 54% of assets are more volatile |
Expected Return
-0.52 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average AIM ImmunoTech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AIM ImmunoTech by adding AIM ImmunoTech to a well-diversified portfolio.
Price Book 4.988 | Enterprise Value Ebitda 0.4928 | Price Sales 72.9296 | Shares Float 48.5 M | Wall Street Target Price 3 |
AIM ImmunoTech Stock Price History Chart
There are several ways to analyze AIM Stock price data. The simplest method is using a basic AIM candlestick price chart, which shows AIM ImmunoTech price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 5, 2024 | 0.33 |
Lowest Price | November 19, 2024 | 0.18 |
AIM ImmunoTech November 30, 2024 Stock Price Synopsis
Various analyses of AIM ImmunoTech's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell AIM Stock. It can be used to describe the percentage change in the price of AIM ImmunoTech from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of AIM Stock.AIM ImmunoTech Price Action Indicator | 0.01 | |
AIM ImmunoTech Accumulation Distribution | 15,626 | |
AIM ImmunoTech Price Rate Of Daily Change | 1.10 | |
AIM ImmunoTech Price Daily Balance Of Power | 1.00 |
AIM ImmunoTech November 30, 2024 Stock Price Analysis
AIM Stock Price History Data
The price series of AIM ImmunoTech for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 has a statistical range of 0.18 with a coefficient of variation of 14.44. The prices are distributed with arithmetic mean of 0.27. The median price for the last 90 days is 0.26. The company had 1:44 stock split on 11th of June 2019. AIM ImmunoTech issued dividends on 2019-06-11.Open | High | Low | Close | Volume | ||
11/29/2024 | 0.23 | 0.24 | 0.22 | 0.23 | 187,515 | |
11/27/2024 | 0.23 | 0.24 | 0.20 | 0.23 | 607,023 | |
11/26/2024 | 0.21 | 0.23 | 0.21 | 0.23 | 229,739 | |
11/25/2024 | 0.21 | 0.22 | 0.21 | 0.21 | 273,493 | |
11/22/2024 | 0.21 | 0.22 | 0.21 | 0.21 | 367,417 | |
11/21/2024 | 0.20 | 0.22 | 0.19 | 0.21 | 794,071 | |
11/20/2024 | 0.19 | 0.20 | 0.18 | 0.20 | 1,012,593 | |
11/19/2024 | 0.23 | 0.26 | 0.16 | 0.18 | 4,293,833 | |
11/18/2024 | 0.22 | 0.26 | 0.22 | 0.23 | 2,765,372 | |
11/15/2024 | 0.24 | 0.25 | 0.22 | 0.22 | 864,053 | |
11/14/2024 | 0.23 | 0.27 | 0.23 | 0.25 | 781,866 | |
11/13/2024 | 0.24 | 0.25 | 0.23 | 0.24 | 311,888 | |
11/12/2024 | 0.23 | 0.25 | 0.23 | 0.24 | 245,718 | |
11/11/2024 | 0.24 | 0.25 | 0.23 | 0.23 | 265,802 | |
11/08/2024 | 0.24 | 0.25 | 0.24 | 0.24 | 222,429 | |
11/07/2024 | 0.25 | 0.26 | 0.24 | 0.24 | 119,817 | |
11/06/2024 | 0.25 | 0.26 | 0.24 | 0.25 | 152,259 | |
11/05/2024 | 0.25 | 0.27 | 0.25 | 0.25 | 49,628 | |
11/04/2024 | 0.27 | 0.27 | 0.25 | 0.26 | 119,672 | |
11/01/2024 | 0.26 | 0.27 | 0.25 | 0.26 | 95,388 | |
10/31/2024 | 0.25 | 0.26 | 0.24 | 0.26 | 317,540 | |
10/30/2024 | 0.27 | 0.27 | 0.25 | 0.25 | 232,309 | |
10/29/2024 | 0.27 | 0.27 | 0.26 | 0.27 | 143,439 | |
10/28/2024 | 0.27 | 0.27 | 0.25 | 0.27 | 611,696 | |
10/25/2024 | 0.27 | 0.27 | 0.25 | 0.27 | 285,727 | |
10/24/2024 | 0.26 | 0.27 | 0.25 | 0.26 | 217,379 | |
10/23/2024 | 0.27 | 0.27 | 0.25 | 0.26 | 227,530 | |
10/22/2024 | 0.27 | 0.28 | 0.25 | 0.27 | 324,748 | |
10/21/2024 | 0.25 | 0.27 | 0.24 | 0.26 | 320,016 | |
10/18/2024 | 0.26 | 0.26 | 0.24 | 0.25 | 149,044 | |
10/17/2024 | 0.25 | 0.27 | 0.24 | 0.26 | 310,567 | |
10/16/2024 | 0.27 | 0.27 | 0.25 | 0.26 | 150,158 | |
10/15/2024 | 0.26 | 0.26 | 0.24 | 0.26 | 250,528 | |
10/14/2024 | 0.27 | 0.28 | 0.25 | 0.26 | 219,906 | |
10/11/2024 | 0.26 | 0.28 | 0.26 | 0.27 | 70,729 | |
10/10/2024 | 0.25 | 0.26 | 0.25 | 0.26 | 90,789 | |
10/09/2024 | 0.26 | 0.27 | 0.25 | 0.26 | 144,682 | |
10/08/2024 | 0.27 | 0.29 | 0.26 | 0.26 | 267,240 | |
10/07/2024 | 0.26 | 0.28 | 0.26 | 0.27 | 404,525 | |
10/04/2024 | 0.25 | 0.27 | 0.24 | 0.26 | 770,988 | |
10/03/2024 | 0.25 | 0.27 | 0.23 | 0.24 | 719,976 | |
10/02/2024 | 0.25 | 0.27 | 0.24 | 0.25 | 278,255 | |
10/01/2024 | 0.26 | 0.27 | 0.25 | 0.26 | 146,096 | |
09/30/2024 | 0.28 | 0.28 | 0.26 | 0.27 | 585,124 | |
09/27/2024 | 0.28 | 0.28 | 0.26 | 0.28 | 125,067 | |
09/26/2024 | 0.26 | 0.28 | 0.25 | 0.27 | 342,425 | |
09/25/2024 | 0.27 | 0.28 | 0.24 | 0.24 | 575,817 | |
09/24/2024 | 0.27 | 0.28 | 0.26 | 0.26 | 355,714 | |
09/23/2024 | 0.26 | 0.27 | 0.23 | 0.25 | 367,158 | |
09/20/2024 | 0.30 | 0.32 | 0.21 | 0.27 | 1,527,490 | |
09/19/2024 | 0.32 | 0.33 | 0.29 | 0.29 | 792,953 | |
09/18/2024 | 0.31 | 0.32 | 0.29 | 0.30 | 257,187 | |
09/17/2024 | 0.33 | 0.33 | 0.30 | 0.31 | 346,769 | |
09/16/2024 | 0.29 | 0.31 | 0.29 | 0.30 | 137,630 | |
09/13/2024 | 0.30 | 0.31 | 0.29 | 0.30 | 169,168 | |
09/12/2024 | 0.31 | 0.33 | 0.29 | 0.30 | 278,853 | |
09/11/2024 | 0.33 | 0.33 | 0.30 | 0.31 | 148,024 | |
09/10/2024 | 0.31 | 0.34 | 0.31 | 0.32 | 44,998 | |
09/09/2024 | 0.32 | 0.33 | 0.31 | 0.33 | 106,759 | |
09/06/2024 | 0.33 | 0.33 | 0.31 | 0.33 | 103,331 | |
09/05/2024 | 0.34 | 0.34 | 0.32 | 0.33 | 103,411 |
About AIM ImmunoTech Stock history
AIM ImmunoTech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for AIM is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in AIM ImmunoTech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing AIM ImmunoTech stock prices may prove useful in developing a viable investing in AIM ImmunoTech
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 48.6 M | 51 M |
AIM ImmunoTech Stock Technical Analysis
AIM ImmunoTech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
All Next | Launch Module |
AIM ImmunoTech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for AIM ImmunoTech's price direction in advance. Along with the technical and fundamental analysis of AIM Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of AIM to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.07) | |||
Jensen Alpha | (0.62) | |||
Total Risk Alpha | (1.41) | |||
Treynor Ratio | (0.96) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AIM ImmunoTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in AIM Stock, please use our How to Invest in AIM ImmunoTech guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AIM ImmunoTech. If investors know AIM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AIM ImmunoTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.004 | Quarterly Revenue Growth 0.19 | Return On Assets (0.80) | Return On Equity (1.55) |
The market value of AIM ImmunoTech is measured differently than its book value, which is the value of AIM that is recorded on the company's balance sheet. Investors also form their own opinion of AIM ImmunoTech's value that differs from its market value or its book value, called intrinsic value, which is AIM ImmunoTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AIM ImmunoTech's market value can be influenced by many factors that don't directly affect AIM ImmunoTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AIM ImmunoTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if AIM ImmunoTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AIM ImmunoTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.